Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 1,845.00
+7.00 (0.38%)
Aug 25, 2026, 3:30 PM JST
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 48.19 billion as of August 24, 2026. Its market cap has increased by 34.42% in one year.
Market Cap
48.19B
Enterprise Value
67.14B
Revenue
60.11B
Ranking
n/a
PE Ratio
15.45
Stock Price
1,845.00
ChartMarket Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 48.19B, an increase of 177.21%. That is a compound annual growth rate of 5.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 48.19B | 4.37% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kissei Pharmaceutical | 169.75B |
| Kaken Pharmaceutical | 150.90B |
| Mochida Pharmaceutical | 115.25B |
| Zeria Pharmaceutical | 94.90B |
| KYORIN Pharmaceutical | 66.52B |
| ASKA Pharmaceutical Holdings | 61.62B |
| Daito Pharmaceutical | 39.18B |
| Mizuho Medy | 32.78B |